Meniscal degeneration. Other meniscus derangements
Conditions
Interventions
Intervention 1: Control group: Routine treatments for knee osteoarthritis include anti-inflammatory medication (500 mg of Naproxen every 12 hours), reducing knee strain through lifestyle changes, and
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Individuals with knee pain Age between 40 and 60 years Meniscal degeneration detected on MRI
Exclusion criteria
Exclusion criteria: History of significant knee trauma Biomechanical abnormalities of the knee Meniscus or ligament tears History of rheumatic diseases History of septic arthritis of the knee Systemic diseases or medications that affect platelet count or function. Malignancy or any severe systemic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Meniscal degeneration on MRI. Timepoint: Before treatment and 4 months after the start of treatment. Method of measurement: Magnetic Resonance Imaging. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain, clinical symptoms, activities of daily living, function, and quality of life. Timepoint: Before treatment and 4 months after the start of treatment. Method of measurement: KOOS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasa Salmani Oshnari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed